Table 1.

Effect of BM-Cell Coating With Anti-Adhesion Molecule MoAbs on Colony Growth In Vitro and In Vivo

BM-Cell Treatment-150CFU-GMBFU-EDay-12 CFU-S
Control Ig 120 ± 31-151   9   31 ± 4 
  (n = 4)-152  (n = 2)   (n = 3) 
Anti-CD44  111 ± 27   10  26 ± 5  
Control Ig  126 ± 32   30 ± 20  31 ± 3  
  (n = 4)   (n = 3)  (n = 4)  
Anti–VLA-4  107 ± 27  28 ± 17   30 ± 7  
Control Ig  126 ± 7  23 ± 14   27 ± 1  
  (n = 3)   (n = 3)   (n = 3)  
Anti-CD11a  90 ± 18  21 ± 10   21 ± 5   
BM-Cell Treatment-150CFU-GMBFU-EDay-12 CFU-S
Control Ig 120 ± 31-151   9   31 ± 4 
  (n = 4)-152  (n = 2)   (n = 3) 
Anti-CD44  111 ± 27   10  26 ± 5  
Control Ig  126 ± 32   30 ± 20  31 ± 3  
  (n = 4)   (n = 3)  (n = 4)  
Anti–VLA-4  107 ± 27  28 ± 17   30 ± 7  
Control Ig  126 ± 7  23 ± 14   27 ± 1  
  (n = 3)   (n = 3)   (n = 3)  
Anti-CD11a  90 ± 18  21 ± 10   21 ± 5   

Comparison of the number of colonies generated by BM cells coated with control rat Ig versus tested antibody was statistically nonsignificant in all cases.

F0-150

107 cells were incubated with 20 μg antibody or rat Ig for 30 minutes on ice and washed.

F0-151

Mean ± SEM of the number of colonies/105 BM cells.

F0-152

n = number of experiments.

Close Modal

or Create an Account

Close Modal
Close Modal